Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
128.35
-1.82 (-1.40%)
Jun 3, 2026, 10:50 AM EDT - Market open
Guardant Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,080 | 982.02 | 739.02 | 563.95 | 449.54 | 373.65 | |
Revenue Growth (YoY) | 39.56% | 32.88% | 31.04% | 25.45% | 20.31% | 30.31% |
Cost of Revenue | 379.2 | 349.01 | 289.8 | 227.05 | 156.33 | 122.91 |
Gross Profit | 701.01 | 633.01 | 449.22 | 336.9 | 293.21 | 250.74 |
Selling, General & Admin | 781.86 | 706.07 | 545.06 | 451.03 | 463.78 | 398.52 |
Research & Development | 366.71 | 364.19 | 347.75 | 367.19 | 373.81 | 263.22 |
Other Operating Expenses | - | - | - | 83.4 | - | - |
Total Operating Expenses | 1,149 | 1,070 | 892.81 | 901.62 | 837.59 | 661.74 |
Operating Income | -447.56 | -437.25 | -443.59 | -564.73 | -544.38 | -411 |
Interest Income | 36.13 | 34.1 | 53.69 | 35.37 | 6.07 | 3.93 |
Interest Expense | -4.45 | -3.9 | -2.58 | -2.58 | -2.58 | -2.58 |
Other Non-Operating Income (Expense) | -18.5 | -10.49 | -42.61 | 53.17 | -112.56 | 25.18 |
Total Non-Operating Income (Expense) | 13.18 | 19.71 | 8.51 | 85.96 | -109.07 | 26.53 |
Pretax Income | -434.37 | -417.54 | -435.09 | -478.76 | -653.45 | -384.47 |
Provision for Income Taxes | -1.18 | -1.26 | 1.28 | 0.99 | 1.14 | 0.3 |
Net Income | -433.19 | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 |
Minority Interest in Earnings | - | - | - | - | - | 20.9 |
Net Income to Common | -433.19 | -416.28 | -436.37 | -479.45 | -654.59 | -405.67 |
Shares Outstanding (Basic) | 127 | 125 | 123 | 112 | 102 | 101 |
Shares Outstanding (Diluted) | 127 | 125 | 123 | 112 | 102 | 101 |
Shares Change (YoY) | 3.19% | 2.14% | 9.61% | 9.60% | 0.85% | 3.91% |
EPS (Basic) | -3.39 | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
EPS (Diluted) | -3.39 | -3.32 | -3.56 | -4.28 | -6.41 | -4.00 |
Shares Outstanding | 131.51 | 130.64 | 123.99 | 121.63 | 102.62 | 101.77 |
Free Cash Flow | -237.12 | -233.07 | -274.94 | -345.46 | -386.92 | -284.05 |
Free Cash Flow Per Share | -1.86 | -1.86 | -2.24 | -3.08 | -3.79 | -2.80 |
Gross Margin | 64.90% | 64.46% | 60.79% | 59.74% | 65.23% | 67.11% |
Operating Margin | -41.43% | -44.53% | -60.02% | -100.14% | -121.10% | -110.00% |
Profit Margin | -40.10% | -42.39% | -59.05% | -85.02% | -145.61% | -102.97% |
FCF Margin | -21.95% | -23.73% | -37.20% | -61.26% | -86.07% | -76.02% |
EBITDA | -408.62 | -397.51 | -401.21 | -521.84 | -508.42 | -388.73 |
EBITDA Margin | -37.83% | -40.48% | -54.29% | -92.53% | -113.10% | -104.04% |
EBIT | -447.56 | -437.25 | -443.59 | -564.73 | -544.38 | -411 |
EBIT Margin | -41.43% | -44.53% | -60.02% | -100.14% | -121.10% | -110.00% |
Effective Tax Rate | 0.27% | 0.30% | -0.30% | -0.21% | -0.17% | -0.08% |